findmyKOL
Clinical trialNCT00252304CompletedPhase 2/PHASE3Interventional

Therapeutic Zinc in Childhood Pneumonia

SponsorCentre For International HealthEnrollment641Pneumonia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this study is to assess whether zinc given as adjuvant therapy to standard antibiotic treatment in children hospitalized for severe pneumonia reduces the duration of the severe illness and risk of treatment failure. A randomized double blind placebo controlled clinical trial will be conducted at the Kanti Hospital.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Halvor Sommerfelt, MD, PhD

    Centre For International Health

    Study Chair
    clinicaltrials.gov ↗
  • Nita Bhandari, MBBS, PhD

    Centre For International Health

    Study Chair
    clinicaltrials.gov ↗
  • Prakash S Shrestha, MD

    Child Health Research Project, Department of Child Health, Institute of Medicine, Maharajganj:

    Study Director
    clinicaltrials.gov ↗
  • Ramesh K Adhikari, MD

    Child Health Research Project, Department of Child Health, Institute of Medicine, Maharajganj:

    Study Chair
    clinicaltrials.gov ↗
  • Sudha Basnet, MD

    Department of Child Health, Institute of Medicine, Tribhuwan University, Katmandu, Nepal

    Principal Investigator
    clinicaltrials.gov ↗
  • Tor A Strand, MD, PhD

    Centre For International Health

    Study Director
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Nepal
  • Kanti Children Hospital

    Kathmandu, Nepal

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboZinc
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2006
Primary completion
31 Jul 2008
Completion
31 Jul 2008
Last update posted
6 Oct 2009
Registered enrollment
641
Registry id
NCT00252304
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.